- Home
- SAIA vs TECH Comparison
SAIA vs TECH Comparison
Compare SAIA & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SAIA | TECH |
|---|---|---|
| Founded | 1924 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.2B |
| IPO Year | 2002 | 1989 |
Fundamental Metrics
Financial Performance| Metric | SAIA | TECH |
|---|---|---|
| Price | $355.54 | $63.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | ★ $354.78 | $70.46 |
| AVG Volume (30 Days) | 444.0K | ★ 1.6M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 10.58 | 0.49 |
| Revenue | ★ $3,233,286,000.00 | $1,216,732,000.00 |
| Revenue This Year | $2.33 | $2.33 |
| Revenue Next Year | $5.09 | $7.05 |
| P/E Ratio | ★ $33.80 | $133.64 |
| Revenue Growth | 1.96 | ★ 3.85 |
| 52 Week Low | $229.12 | $46.01 |
| 52 Week High | $538.03 | $79.28 |
Technical Indicators
Market Signals| Indicator | SAIA | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 61.96 |
| Support Level | $323.09 | $58.40 |
| Resistance Level | $369.83 | $66.48 |
| Average True Range (ATR) | 11.23 | 1.56 |
| MACD | 1.51 | 0.74 |
| Stochastic Oscillator | 75.27 | 72.46 |
Price Performance
Historical ComparisonAbout SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.